Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension.
about
Review article: primary prophylaxis for portal hypertensive bleeding in cirrhosis.Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits.Nitric oxide and the liver.Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.Management of bleeding in the cirrhotic patient.Bleeding esophagogastric varices. Ways to treat active episodes and prevent recurrence.Purinergic receptors in the splanchnic circulation.Nonendoscopic management strategies for acute esophagogastric variceal bleeding.Murine study of portal hypertension associated endothelin-1 hypo-responseEffects of pharmacological serum from normal and liver fibrotic rats on HSCs.Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.Intrahepatic portal occlusion by microspheres: a new model of portal hypertension in the rat.A non-invasive method for evaluating cirrhotic portal hypertension by administration of 99mTc-MIBI per rectum.Altered alpha adrenergic vasoresponsiveness in a non-cirrhotic portal hypertension model of E. coli injection.Portal blood flow in acute hepatitis with and without ascites: A non-invasive measurement using an ultrasonic Doppler
P2860
Q33961964-C90D06E2-7352-4E34-BDDE-BC8C98583650Q34153535-D6149FB2-24E7-4501-A35C-5AA38533D53AQ34291742-6E23AA34-4D89-4743-8471-CE9AB129BE25Q34309152-5AAED2B2-C813-471E-9ED8-8D3851333B49Q34619310-95263F4E-9254-45FB-89FF-028712BBC040Q36492925-F4974EC8-2AEC-4748-A5D6-68FCE1BC03AAQ37150015-D532DDA4-B88B-4C56-BCDF-8CEE33EF592CQ38273947-9ADC3698-4F50-49A8-9D37-8129FB5B5F75Q39923460-F7AA588D-276E-47A9-9161-7837484E2616Q40434834-10F8F612-A2BB-42B5-9ADE-261D6B18BB40Q42109164-06455794-2F98-4C0A-B13A-D134342FFC4FQ43213888-9FC89778-4943-4D3C-978C-4CF59675EC2BQ52348325-77ED3C51-1BC4-40E6-B236-159492859F1DQ54439827-FA6B80F7-C752-4DFB-AA11-890A5A3FD49FQ57205726-0298B4B0-6DF9-4E8C-B495-3E0C479A1D23
P2860
Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Liver function and pharmacolog ...... atment of portal hypertension.
@en
Liver function and pharmacolog ...... atment of portal hypertension.
@nl
type
label
Liver function and pharmacolog ...... atment of portal hypertension.
@en
Liver function and pharmacolog ...... atment of portal hypertension.
@nl
prefLabel
Liver function and pharmacolog ...... atment of portal hypertension.
@en
Liver function and pharmacolog ...... atment of portal hypertension.
@nl
P921
P356
P1433
P1476
Liver function and pharmacolog ...... atment of portal hypertension.
@en
P2093
P304
P356
10.1002/HEP.1840110625
P407
P577
1990-06-01T00:00:00Z